ES514868A0 - "un procedimiento para la preparacion de un derivado de tiazol". - Google Patents

"un procedimiento para la preparacion de un derivado de tiazol".

Info

Publication number
ES514868A0
ES514868A0 ES514868A ES514868A ES514868A0 ES 514868 A0 ES514868 A0 ES 514868A0 ES 514868 A ES514868 A ES 514868A ES 514868 A ES514868 A ES 514868A ES 514868 A0 ES514868 A0 ES 514868A0
Authority
ES
Spain
Prior art keywords
tiazole
derivative
procedure
preparation
tiazole derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES514868A
Other languages
English (en)
Other versions
ES8306135A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES514868(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES514868A0 publication Critical patent/ES514868A0/es
Publication of ES8306135A1 publication Critical patent/ES8306135A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
ES514868A 1980-10-02 1982-08-09 "un procedimiento para la preparacion de un derivado de tiazol". Expired ES8306135A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (2)

Publication Number Publication Date
ES514868A0 true ES514868A0 (es) 1983-05-01
ES8306135A1 ES8306135A1 (es) 1983-05-01

Family

ID=22712591

Family Applications (2)

Application Number Title Priority Date Filing Date
ES505950A Expired ES8301950A1 (es) 1980-10-02 1981-10-01 Un procedimiento para la preparacion de un derivado de tia- zol
ES514868A Expired ES8306135A1 (es) 1980-10-02 1982-08-09 "un procedimiento para la preparacion de un derivado de tiazol".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES505950A Expired ES8301950A1 (es) 1980-10-02 1981-10-01 Un procedimiento para la preparacion de un derivado de tia- zol

Country Status (36)

Country Link
US (1) US4375547A (es)
EP (1) EP0049618B1 (es)
JP (1) JPS5791980A (es)
KR (1) KR850001795B1 (es)
AR (1) AR241439A1 (es)
AU (1) AU542553B2 (es)
BG (1) BG60249B2 (es)
CA (1) CA1166248A (es)
CS (1) CS227015B2 (es)
CY (1) CY1351A (es)
DD (1) DD200371A5 (es)
DE (1) DE3171819D1 (es)
DK (2) DK164056C (es)
EG (1) EG15678A (es)
ES (2) ES8301950A1 (es)
FI (2) FI813058L (es)
GB (1) GB2084581B (es)
GR (1) GR75023B (es)
HK (1) HK15987A (es)
HU (1) HU188697B (es)
IE (1) IE51603B1 (es)
IL (1) IL63980A (es)
LU (1) LU88293I2 (es)
MX (1) MX5723A (es)
MY (1) MY8700247A (es)
NL (1) NL930107I2 (es)
NO (1) NO155885C (es)
NZ (1) NZ198523A (es)
PH (1) PH18135A (es)
PL (2) PL130526B1 (es)
PT (1) PT73757B (es)
RO (2) RO85815B (es)
SU (1) SU1184443A3 (es)
UA (1) UA6081A1 (es)
YU (1) YU42728B (es)
ZA (1) ZA816817B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
FI840474A (fi) * 1983-02-07 1984-08-08 Lilly Co Eli Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna.
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
EP0230127A1 (en) * 1985-12-18 1987-07-29 Eli Lilly And Company Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
DE3784698D1 (de) * 1987-04-06 1993-04-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
EP0515121B1 (en) * 1991-05-21 2000-11-02 Eli Lilly And Company Process for preparing intermediates to nizatidine and related compounds
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
EP0641763B1 (en) * 1992-05-12 1997-01-08 Zeria Pharmaceutical Co., Ltd. Novel quaternary ammonium salts and use thereof as medicine
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
KR20000036016A (ko) * 1996-09-11 2000-06-26 독터. 호르스트 하스칼, 잉에 린스 니자티딘의 제조 방법
IT1299198B1 (it) * 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
WO2000028988A1 (en) 1998-11-17 2000-05-25 Nitromed, Inc. Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1750674A4 (en) * 2004-05-27 2012-05-23 Advanced Bionutrition Corp MICROPARTICLES FOR THE ORAL LEVY
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
WO2013135852A1 (en) 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
EA034430B1 (ru) 2013-07-19 2020-02-06 Бёрингер Ингельхайм Ветмедика Гмбх Жидкая водная фармацевтическая композиция с консервантами, содержащая этерифицированные производные циклодекстрина
ES2883448T3 (es) 2013-12-04 2021-12-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmacéuticas mejoradas de pimobendán
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
DE2963363D1 (en) * 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
NO155885B (no) 1987-03-09
AU7594581A (en) 1982-04-08
FI813058L (fi) 1982-04-03
NZ198523A (en) 1985-12-13
PT73757B (en) 1983-01-13
PL233295A1 (es) 1982-12-20
SU1184443A3 (ru) 1985-10-07
KR830007602A (ko) 1983-11-04
PH18135A (en) 1985-04-03
JPH021141B2 (es) 1990-01-10
DK164056B (da) 1992-05-04
DD200371A5 (de) 1983-04-20
YU236481A (en) 1983-10-31
RO85815B (ro) 1984-11-30
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
MY8700247A (en) 1987-12-31
AR241439A1 (es) 1992-07-31
KR850001795B1 (ko) 1985-12-21
PL130626B1 (en) 1984-08-31
DK435181A (da) 1982-05-12
PL130526B1 (en) 1984-08-31
GB2084581A (en) 1982-04-15
ZA816817B (en) 1983-05-25
CA1166248A (en) 1984-04-24
GB2084581B (en) 1985-02-27
GR75023B (es) 1984-07-12
EP0049618B1 (en) 1985-08-14
MX5723A (es) 1993-12-01
PL238035A1 (en) 1983-02-28
RO82215A (ro) 1983-07-07
EG15678A (en) 1986-12-30
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
HK15987A (en) 1987-02-27
AU542553B2 (en) 1985-02-28
RO82215B (ro) 1983-06-30
PT73757A (en) 1981-11-01
NO155885C (no) 1987-06-17
BG60249B1 (bg) 1994-03-24
IE51603B1 (en) 1987-01-21
BG60249B2 (en) 1994-03-24
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
IE812285L (en) 1982-04-02
YU42728B (en) 1988-12-31
ES8306135A1 (es) 1983-05-01
IL63980A (en) 1986-04-29
DK12391A (da) 1991-01-24
NL930107I1 (nl) 1993-10-18
NL930107I2 (nl) 1997-02-03
HU188697B (en) 1986-05-28
NO813334L (no) 1982-04-05
JPS5791980A (en) 1982-06-08
RO85815A (ro) 1984-11-25
IL63980A0 (en) 1982-01-31
DK164056C (da) 1992-09-28
DK12391D0 (da) 1991-01-24
DE3171819D1 (en) 1985-09-19
ES505950A0 (es) 1983-01-01
ES8301950A1 (es) 1983-01-01
EP0049618A1 (en) 1982-04-14
DK167759B1 (da) 1993-12-13
US4375547A (en) 1983-03-01

Similar Documents

Publication Publication Date Title
ES514868A0 (es) "un procedimiento para la preparacion de un derivado de tiazol".
ES508286A0 (es) Un procedimiento para la preparacion de derivados de imidazolil-propanol.
ES507298A0 (es) Un procedimiento para la preparacion de derivados de 2-feniletanolamina.
ES512076A0 (es) "un procedimiento para la preparacion de piridin- y piracin-derivados".
ES519057A0 (es) Un procedimiento para la preparacion de derivados de caprolactama.
ES515295A0 (es) "un procedimiento para la preparacion de imidazoquinazolinas".
ES514992A0 (es) Un procedimiento para la preparacion de un derivado carbostirilo.
ES507755A0 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
ES501339A0 (es) Un procedimiento para la preparacion de derivados de 9-carbamoil-9-aminoalquilfluoreno.
ES504790A0 (es) Un procedimiento para la preparacion de derivados de enantolactama.
ES501432A0 (es) Un procedimiento para la preparacion de 4,5-diaril-&-cpolifluoralquil)-1-4-pirrol-2metanaminas antiinflamatorias.
ES512079A0 (es) "un procedimiento para la preparacion de nuevos acilderivados de cefalosporina".
ES511039A0 (es) "un procedimiento para la preparacion de derivados de adenosina".
ES508809A0 (es) Un procediemento para la preparacion de un derivado de piridoindol.
ES510908A0 (es) "un procedimiento para la preparacion de derivados de piridinona".
ES503338A0 (es) Un procedimiento para la preparacion de derivados de bis-hidroxibencilo.
ES504577A0 (es) Un procedimiento para la preparacion de derivados de piridazinona.
ES505920A0 (es) Un procedimiento para la preparacion de derivados de isonicotinanilida.
ES514572A0 (es) "un procedimiento para la preparacion de glutation".
ES510286A0 (es) "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas".
ES508152A0 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
ES514571A0 (es) "un procedimiento para la preparacion de glutation".
ES510928A0 (es) "un procedimiento para la preparacion de mercapto-acil-carnitinas".
ES499443A0 (es) Un procedimiento para la preparacion de derivados de 2-desoxi-3-5-di-o-alquilcarbonil-5-fluorurina.
ES508723A0 (es) "un procedimiento para la preparacion de derivados de metoxicefalosporinas".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20030225